Details for 2018201062
Up to date per 01.04.2026
Actions
Details for 2018201062
Granted/Registered
European Patent
13.03.2019 A
03.06.2020 B1
22.12.2008
US
139672 P
19.06.2009
US
218530 P
29.09.2009
US
246715 P
A61K 31/137 20060101AFI20200310BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
SCHMOUDER, RobertNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US
DUMORTIER, ThomasNovartis Pharma AG Postfach 4002 BaselCH
DAVID, OlivierNovartis Pharma AG Postfach 4002 BaselCH
LOOBY, MichaelNovartis Pharma AG Postfach 4002 BaselCH
Information about Fees